Pharmacross announces an exclusive distribution agreement with Pamas Trading srl to commercialize its full product portfolio in Romania. This strategic partnership combines Pharmacross’ innovative veterinary products with Pamas Trading’s expertise and established presence in the Romanian veterinary market, strengthening the company’s international distribution network.

Pharmacross’ dMEGA3 and kcMEGA3 feature highly concentrated omega-3 fatty acids (over 90%), mixed tocopherols for antioxidant protection, and fish gelatin capsules. Enhanced by innovative LIPIDcaps™ technology, they offer improved absorption, faster onset of action, reduced gastric irritation, and greater stability, setting high standards in veterinary nutrition.

dMEGA3 by Pharmacross is a high-quality omega-3 complementary feed specifically formulated to support skin function in dogs and cats affected by dermatosis and excessive hair loss. Rich in EPA and DHA, it features fish gelatin capsules, high-purity ingredients, and stringent quality controls, reflecting Pharmacross’ commitment to scientific excellence and veterinary nutrition.

Pharmacross held another successful meeting in Malta with its distribution partners Sia Universitates Vetfonds (Latvia) and UAB Vetslénis (Lithuania). The event focused on sharing new projects, providing technical training, and strengthening long-standing partnerships through collaboration and mutual growth.

Omega-3 fatty acids EPA and DHA, found in fish oil, have shown beneficial effects in dogs with heart disease, as highlighted by Tufts University's Cummings School of Veterinary Medicine. Pharmacross’ kcMEGA3 provides an excellent source of these essential fatty acids, supporting cardiovascular health in companion animals.

Research highlighted by Tufts University emphasizes the benefits of omega-3 fatty acids from fish oil in managing various canine and feline diseases, while warning against potential contaminants in low-quality oils. Pharmacross prioritizes pet safety by selecting high-quality fish oils certified free from toxic substances, heavy metals, and vitamins A and D.

Pharmacross welcomes Dr. Paola D’Ippolito, M.Sc., DVM, as its new R&D Manager. With extensive experience in small animal internal medicine, nephrology, and intensive care, she will work alongside CSO Dr. Andrea Zatelli to advance research and development, exploring innovative and reliable nutraceutical solutions for veterinary professionals.

Pharmacross announces an exclusive distribution agreement with Agrimed Ltd to commercialize its full product portfolio in Malta. This strategic partnership combines Pharmacross’ innovative veterinary products with Agrimed’s established expertise and distribution network, strengthening the company’s presence in the Maltese animal health market.

jGARD® is a high-quality complementary feed formulated to support joint function in dogs with osteoarthritis. Combining high-purity glucosamine, chondroitin sulfate, and omega-3 fatty acids (EPA & DHA), it is manufactured under strict quality standards and supported by veterinary research. Available in capsules and paste, jGARD® offers tailored nutritional support for dogs of all sizes.

Pharmacross welcomes Dr. Adriano Casella to its Technical Department, where he will contribute to scientific activities and product development strategies. Working alongside CSO Dr. Andrea Zatelli, he will focus on evaluating the existing product portfolio and planning new product launches, supporting the company’s innovation and growth.